Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details)

v3.10.0.1
Note 9 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Details    
Real estate note $ 113,074 $ 116,632
Working capital note 919,057 764,389
Note receivable discount (8,351) 0
Accrued interest 3,140 0
Less current portion (44,346) (35,445)
Long term portion of notes receivable $ 982,574 $ 845,576